Invitation to presentation in connection with EQL Pharma's interim report, second quarter, 2024/25

EQL Pharma AB (publ) will publish its interim report for the second quarter, 2024/25, on Wednesday, November 6^th, before stock markets opening.

At 10.00 (CET) 6^th November, the company will give a presentation via video conference. The presentation is aimed at shareholders and potential shareholders. CEO and President Axel Schörling presents and comments on the interim report. After the presentation, there is an opportunity to ask questions for those who participate.

Use the following link to access the virtual meeting: https://tinyurl.com/jszm8ecf

Date and time

November 6^th, 2024, at 10.00 (CET) the presentation starts. Time required for presentation and subsequent question time is estimated at a maximum 1 hour.

Make sure you are able to attend the video conference by logging in shortly before the start of the conference.